Severe Strongyloidiasis Infection Reported in Kidney Transplant Recipients
By LabMedica International staff writers Posted on 25 Feb 2020 |
Image: Microscopic examination of bronchoalveolar lavage fluid revealing the presence of Strongyloides stercoralis larvae in hemorrhagic background (Photo courtesy Kyung-Nyeo Jeon, MD, PhD).
Strongyloides stercoralis is a soil-transmitted human pathogenic parasitic roundworm causing the disease strongyloidiasis. It is found in tropical and subtropical regions worldwide. Many people infected are asymptomatic at first. Symptoms include dermatitis: swelling, itching, larva currens, and mild hemorrhage at the site where the skin has been penetrated.
Although infections are usually mild or asymptomatic, they can be severe, with high mortality rates, in patients receiving immunosuppressive therapy, including organ transplant recipients. It is therefore relevant for countries endemic for infectious diseases such as strongyloidiasis to have a special focus on endemic diseases in organ transplant recipients.
Infectious disease specialists at the Universidade Federal de São Paulo (São Paulo, Brazil) and their colleagues carried out a retrospective, multicenter, case–control study in which they assessed the risk factors for and clinical outcomes of severe S. stercoralis infections in kidney transplant recipients in Brazil. They included 138 kidney transplant recipients: 46 cases and 92 controls.
Cases were included on the basis of the following criteria: being a kidney or kidney–pancreas transplant recipient; being ≥ 18 years of age; and having been diagnosed with severe S. stercoralis infection, characterized by severe symptoms attributed exclusively to the S. stercoralis life cycle (intense respiratory, gastrointestinal, or other symptoms), together with the isolation of S. stercoralis in sputum, tracheal aspirates, bronchoalveolar lavage fluid, duodenal aspirate, stool samples, pulmonary biopsy samples, or gastrointestinal biopsy samples.
The scientists reported that during the study period, 15,860 transplants were performed and a total of 53 patients were diagnosed with S. stercoralis infection. Of those 53 patients, 46 (45 recipients of a kidney transplant and one recipient of a kidney–pancreas transplant) met the criteria for severe S. stercoralis infection (an incidence of 0.29%) and were matched to 92 control patients. Among the cases, the median number of days from transplantation to diagnosis was 117 (interquartile range [IQR], 73.5–965) and the most common clinical findings were gastrointestinal symptoms (in 78.3%) and respiratory symptoms (in 39.1%), whereas fever and eosinophilia were seen in only 32.6% and 43.5%, respectively. The 30-day all-cause mortality among the cases was 28.3% overall and was significantly higher among the cases of infection occurring within the first three months after transplantation (47% versus 17.2%).
The authors concluded that severe S. stercoralis infections are associated with considerable morbidity and mortality after kidney transplantation. In endemic areas, such infection may occur late after transplantation, although it seems to be more severe when it occurs earlier after transplantation. Specific risk factors and clinical manifestations can identify patients at risk, who should receive prophylaxis or early treatment. The study was published on January 31, 2020 in the journal PLOS Neglected Tropical Diseases.
Related Links:
Universidade Federal de São Paulo
Although infections are usually mild or asymptomatic, they can be severe, with high mortality rates, in patients receiving immunosuppressive therapy, including organ transplant recipients. It is therefore relevant for countries endemic for infectious diseases such as strongyloidiasis to have a special focus on endemic diseases in organ transplant recipients.
Infectious disease specialists at the Universidade Federal de São Paulo (São Paulo, Brazil) and their colleagues carried out a retrospective, multicenter, case–control study in which they assessed the risk factors for and clinical outcomes of severe S. stercoralis infections in kidney transplant recipients in Brazil. They included 138 kidney transplant recipients: 46 cases and 92 controls.
Cases were included on the basis of the following criteria: being a kidney or kidney–pancreas transplant recipient; being ≥ 18 years of age; and having been diagnosed with severe S. stercoralis infection, characterized by severe symptoms attributed exclusively to the S. stercoralis life cycle (intense respiratory, gastrointestinal, or other symptoms), together with the isolation of S. stercoralis in sputum, tracheal aspirates, bronchoalveolar lavage fluid, duodenal aspirate, stool samples, pulmonary biopsy samples, or gastrointestinal biopsy samples.
The scientists reported that during the study period, 15,860 transplants were performed and a total of 53 patients were diagnosed with S. stercoralis infection. Of those 53 patients, 46 (45 recipients of a kidney transplant and one recipient of a kidney–pancreas transplant) met the criteria for severe S. stercoralis infection (an incidence of 0.29%) and were matched to 92 control patients. Among the cases, the median number of days from transplantation to diagnosis was 117 (interquartile range [IQR], 73.5–965) and the most common clinical findings were gastrointestinal symptoms (in 78.3%) and respiratory symptoms (in 39.1%), whereas fever and eosinophilia were seen in only 32.6% and 43.5%, respectively. The 30-day all-cause mortality among the cases was 28.3% overall and was significantly higher among the cases of infection occurring within the first three months after transplantation (47% versus 17.2%).
The authors concluded that severe S. stercoralis infections are associated with considerable morbidity and mortality after kidney transplantation. In endemic areas, such infection may occur late after transplantation, although it seems to be more severe when it occurs earlier after transplantation. Specific risk factors and clinical manifestations can identify patients at risk, who should receive prophylaxis or early treatment. The study was published on January 31, 2020 in the journal PLOS Neglected Tropical Diseases.
Related Links:
Universidade Federal de São Paulo
Latest Pathology News
- New Blood Test Device Modeled on Leeches to Help Diagnose Malaria
- Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing
- Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization
- First of Its Kind Universal Tool to Revolutionize Sample Collection for Diagnostic Tests
- AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis
- New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance
- New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis
- Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse
- Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection
- Image-Based AI Shows Promise for Parasite Detection in Digitized Stool Samples
- Deep Learning Powered AI Algorithms Improve Skin Cancer Diagnostic Accuracy
- Microfluidic Device for Cancer Detection Precisely Separates Tumor Entities
- Virtual Skin Biopsy Determines Presence of Cancerous Cells
- AI Detects Viable Tumor Cells for Accurate Bone Cancer Prognoses Post Chemotherapy
- First Ever Technique Identifies Single Cancer Cells in Blood for Targeted Treatments
- Innovative Blood Collection Device Overcomes Common Obstacles Related to Phlebotomy